Literature DB >> 23887895

Use of insulin to decrease septic shock-induced myocardial depression in a porcine model.

Yosef Levenbrown1, Scott Penfil, Elena Rodriguez, Yan Zhu, Jobayer Hossain, A Majeed Bhat, Anne Hesek, Karen B O'Neil, Kelly Tobin, Thomas H Shaffer.   

Abstract

Insulin is known to attenuate septic shock-induced myocardial depression. Possible mechanisms include an anti-inflammatory or inotropic effect of insulin. The objective of this study was to determine whether the mechanism of action of insulin in attenuating septic shock-induced myocardial depression is through an immunomodulatory effect. Fourteen pigs were assigned to one of two groups. Both groups received a 4-h infusion of lipopolysaccharide endotoxin from Escherichia coli 0111:B4. Group 2 additionally received insulin at 1.5 U/kg/h with infusions of D50 normal saline and KCl to maintain normal serum glucose and potassium levels. Cardiac function was measured with shortening fraction using transthoracic echocardiogram. Plasma TNF-α, IL-1β, and IL-6 levels were obtained every 30 min. Postmortem cytokine analysis and histomorphology were performed on the heart tissue. Although insulin attenuated septic shock-induced myocardial depression, this was not due to an anti-inflammatory effect and, therefore, likely resulted from an inotropic effect of insulin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887895      PMCID: PMC3933170          DOI: 10.1007/s10753-013-9691-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  32 in total

1.  Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase.

Authors:  Nazima Pathan; Joanne L Franklin; Hariklia Eleftherohorinou; Victoria J Wright; Cheryl A Hemingway; Simon J Waddell; Michael Griffiths; Jayne L Dennis; David A Relman; Sian E Harding; Michael Levin
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

2.  Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide.

Authors:  A Aljada; R Saadeh; E Assian; H Ghanim; P Dandona
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

3.  Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia.

Authors:  Reut Fallach; Asher Shainberg; Orna Avlas; Michael Fainblut; Yelena Chepurko; Eyal Porat; Edith Hochhauser
Journal:  J Mol Cell Cardiol       Date:  2010-03-04       Impact factor: 5.000

4.  Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model.

Authors:  Joel S Holger; David J Dries; Kelly W Barringer; Benjamin J Peake; Thomas J Flottemesch; John J Marini
Journal:  Acad Emerg Med       Date:  2010-04       Impact factor: 3.451

5.  Plasma levels of tumor necrosis factor-α and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase.

Authors:  Cho-Kai Wu; Jen-Kuang Lee; Fu-Tien Chiang; Chic-Hsin Yang; Shui-Wei Huang; Juey-Jen Hwang; Jiunn-Lee Lin; Chuen-Den Tseng; Jin-Jer Chen; Chia-Ti Tsai
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

6.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

Authors:  P Dandona; A Aljada; P Mohanty; H Ghanim; W Hamouda; E Assian; S Ahmad
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

7.  Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation.

Authors:  Huaqing Zhu; Limei Shan; Peter W Schiller; Antonello Mai; Tianqing Peng
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

Review 8.  Cardiac dysfunction in severe sepsis and septic shock.

Authors:  Sergio L Zanotti-Cavazzoni; Steven M Hollenberg
Journal:  Curr Opin Crit Care       Date:  2009-10       Impact factor: 3.687

9.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

10.  Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages.

Authors:  Mareike Leffler; Thomas Hrach; Michael Stuerzl; Raymund E Horch; David N Herndon; Marc G Jeschke
Journal:  J Surg Res       Date:  2007-06-20       Impact factor: 2.192

View more
  2 in total

1.  Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.

Authors:  Won-Young Kim; Moon Seong Baek; Young Shin Kim; Jarim Seo; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  The effect of positive end-expiratory pressure on cardiac output and oxygen delivery during cardiopulmonary resuscitation.

Authors:  Yosef Levenbrown; Md Jobayer Hossain; James P Keith; Katlyn Burr; Anne Hesek; Thomas Shaffer
Journal:  Intensive Care Med Exp       Date:  2020-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.